{"name":"Ergonovine","slug":"ergonovine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Ergobasine","Ergotocine","Ergostetrine","Margonovine","Ergoklinine","Ergometrin","Ergometrina","Secacornin","Ergometrinum","Secometrin"],"brands":[],"scraped":true,"has_structure":true,"cid":443884,"classes":[],"families":[{"name":"lysergamide","href":"/substituted/lysergamide"}],"physical":[{"label":"Molecular mass","value":"325.40 g/mol","copyable":false},{"label":"Appearance","value":"Plates or needles","copyable":false},{"label":"Melting point","value":"162 °C","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitrogen oxides/.","copyable":false},{"label":"Solubility","value":"2.68 mg/mL at 25 °C","copyable":false},{"label":"Predicted LogP","value":"1.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"(6aR,9R)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","copyable":true},{"label":"SMILES","value":"C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C","copyable":true},{"label":"InChI","value":"InChI=1S/C19H23N3O2/c1-11(10-23)21-19(24)13-6-15-14-4-3-5-16-18(14)12(8-20-16)7-17(15)22(2)9-13/h3-6,8,11,13,17,20,23H,7,9-10H2,1-2H3,(H,21,24)/t11-,13+,17+/m0/s1","copyable":true},{"label":"InChIKey","value":"WVVSZNPYNCNODU-XTQGRXLLSA-N","copyable":true},{"label":"CAS number","value":"60-79-7","copyable":true},{"label":"UNII","value":"WH41D8433D","copyable":true},{"label":"PubChem CID","value":"443884","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"2-phase (10 min; 2 hours)","copyable":false},{"label":"Metabolism","value":"Liver (partly CYP3A4)","copyable":false},{"label":"Excretion","value":"Bile duct","copyable":false},{"label":"Routes of administration","value":"oral, intramuscular, intravenous","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Ergonovine maleate","name":"maleate","slug":"ergonovine_maleate","drawn":true},{"title":"Ergonovine hemitartrate","name":"hemitartrate","slug":"ergonovine_hemitartrate","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Ehrlich","reacts":true,"colors":["#ffffff","#d59aca","#ff6fcf","#50268d"],"description":"purple"},{"reagent":"Hofmann","reacts":true,"colors":["#ffffff","#0067ce"],"description":"blue"}],"atc":[{"code":"G","description":"Genito urinary system and sex hormones"},{"code":"G02","description":"Other gynecologicals"},{"code":"G02A","description":"Uterotonics"},{"code":"G02AB","description":"Ergot alkaloids"},{"code":"G02AB03","description":""},{"code":"G02AB03","description":"Ergometrine"}],"mesh":[{"name":"Oxytocics","id":"M0015702"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["induction","metabolism","inhibition"],"partners":69,"contraindicated":9},{"target":"ADRA1A","mechanisms":["shared target"],"partners":2,"contraindicated":0},{"target":"ADRA1B","mechanisms":["shared target"],"partners":2,"contraindicated":0},{"target":"ADRA1D","mechanisms":["shared target"],"partners":2,"contraindicated":0},{"target":"ADRA2A","mechanisms":["shared target"],"partners":1,"contraindicated":0},{"target":"ADRA2B","mechanisms":["shared target"],"partners":1,"contraindicated":0},{"target":"ADRA2C","mechanisms":["shared target"],"partners":1,"contraindicated":0}],"mechanism":"Ergonovine directly stimulates the uterine muscle to increase force and frequency of contractions. With usual doses, these contractions precede periods of relaxation; with larger doses, basal uterine tone is elevated and these relaxation periods will be decreased. Contraction of the uterine wall around bleeding vessels at the placental site produces hemostasis. Ergonovine also induces cervical contractions. The sensitivity of the uterus to the oxytocic effect is much greater toward the end of pregnancy. The oxytocic actions of ergonovine are greater than its vascular effects. Ergonovine, like other ergot alkaloids, produces arterial vasoconstriction by stimulation of alpha-adrenergic and serotonin receptors and inhibition of endothelial-derived relaxation factor release. It is a less potent vasoconstrictor than ergotamine. As a diagnostic aid (coronary vasospasm), ergonovine causes vasoconstriction of coronary arteries.","side_effects":{"drug_id":3250,"drug_name":"ergonovine","url":"https://sideeffects.embl.de/drugs/3250/pt","atc_codes":["G02AB03"],"side_effects":[{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Chest pain","cui":"C0008031"},{"name":"Arteriospasm coronary","cui":"C0010073"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Dizziness","cui":"C0012833"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Oesophageal spasm","cui":"C0014863"},{"name":"Gangrene","cui":"C0017086"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Haematuria","cui":"C0018965"},{"name":"Hypertension","cui":"C0020538"},{"name":"Hypotension","cui":"C0020649"},{"name":"Muscle spasms","cui":"C0037763"},{"name":"Myasthenia gravis","cui":"C0026896"},{"name":"Myocardial infarction","cui":"C0027051"},{"name":"Acute coronary syndrome","cui":"C0948089"},{"name":"Nasal congestion","cui":"C0027424"},{"name":"Nausea","cui":"C0027497"},{"name":"Palpitations","cui":"C0030252"},{"name":"Pulmonary oedema","cui":"C0034063"},{"name":"Shock","cui":"C0036974"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Thrombophlebitis","cui":"C0040046"},{"name":"Tinnitus","cui":"C0040264"},{"name":"Vertigo","cui":"C0042571"},{"name":"Vomiting","cui":"C0042963"},{"name":"Water intoxication","cui":"C0043049"},{"name":"Ventricular arrhythmia","cui":"C0085612"},{"name":"Vasospasm","cui":"C0085616"},{"name":"Intestinal infarction","cui":"C0241950"},{"name":"Pleural fibrosis","cui":"C2720436"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Drug interaction","cui":"C0687133"},{"name":"Intestinal ischaemia","cui":"C2004435"}],"indications":[{"name":"Post abortion haemorrhage","cui":"C0854265"},{"name":"Postpartum haemorrhage","cui":"C0032797"},{"name":"Uterine atony","cui":"C0042135"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"D1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule VI","act":null,"refs":[]},{"jurisdiction":"United States","status":"Rx only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Ergonovine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/443884"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q424508"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01253"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL119443"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A4822"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=60-79-7"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015383"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07543"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8046323"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Ergonovine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/WH41D8433D"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/3250/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 443884, Ergonovine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/443884>https://pubchem.ncbi.nlm.nih.gov/compound/443884</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ergonovine. UNII: WH41D8433D. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WH41D8433D>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WH41D8433D</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 03:05:37","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 03:05:33","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 03:05:33","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 03:05:35","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 03:05:33","note":"hmdb.ca refused automated access to HMDB0015383"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 03:05:35","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 03:05:33","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 03:05:33","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 03:05:33","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 03:05:33","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 03:05:34","note":null}],"description":"Ergonovine is a  substance."}